Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has continued its stock buy-back program, purchasing an additional 5,000 shares on the previous day, bringing the total bought back shares to 28,505. This move is part of an ongoing effort to return value to shareholders, with the latest transaction details provided in their daily buy-back notification to the ASX under the security code CUV for ordinary fully paid shares.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
